Search
for
Sort by
Research 571–600 of 1000+
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- Amphiregulin in Fibrotic Diseases and Cancer
- Eyelash trichomegaly complicating pembrolizumab for colorectal cancer
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Targeted Treatments of Non-Small Cell Lung Cancer (NSCLC): Skin Toxicity
- THERAPEUTIC ASPECTS OF ONION IN TREATMENT OF CANCER AND RELATED ISSUES: A REVIEW
- Prevalence and Partern of Early Adverse Reactions in Cancer Patients Receiving Chemotherapy at Ocean Road Cancer Institute
- Psychosocial Effect of Appearance Changes Associated With Cancer: A Scoping Review
- Regulatory mechanisms of LGR4 on cancer and cancer stem cell properties
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Cold Atmospheric Plasma for Breast Cancer
- Genetic Variation in CYP2B6, UGT1A4 and Sulfotransferases Is Associated with Disease-Free Survival in South African Breast Cancer Patients Treated with Tamoxifen
- Nano-Enabled CRISPR-Cas Gene Editing for Cancer Therapeutics
- Ayurveda-Based Supportive Care Using Guduchi, Ashwagandha, and Curcumin for Breast Cancer Patients: A Pilot Observational Study on Quality of Life and Safety
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Environmental factors influencing hormone receptor positive breast cancer incidence: integrating chemical signatures from dust wipes with self-reported sources of exposure
- ANALYSIS OF ADVERSE DRUG REACTIONS (ADRs) AND THEIR SEVERITY IN BREAST CANCER PATIENTS TREATED WITH THE DOCETAXEL-DOXORUBICIN REGIMEN AT SULTAN AGUNG ISLAMIC HOSPITAL
- Dynamic changes of gut and skin microbiota in pancreatic cancer-induced skin injury
- Signal integrator function of CXXC5 in Cancer
- An in vitro study on the effects of homeopathic Radium bromatum (9CH, 12CH, and 30CH potencies) on cancer cells
- LB919 Increased risk of skin cancer and other malignancies in patients with cutaneous lupus erythematous
- Feasibility and tolerability of eribulin-based chemotherapy versus other chemotherapy regimens for patients with metastatic triple-negative breast cancer: a single-centre retrospective study
- Heavy metals in biological samples of cancer patients: a systematic literature review
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Spironolactone use and the risk of breast cancer
- Functional analysis of collagen XVII in epithelial cancers and a mouse model
- Regulation of self-renewal in colorectal cancer cell models
- 1452 DETECTION RATE OF CLINICALLY INSIGNIFICANT PROSTATE CANCER INCREASES WITH REPEATING PROSTATE BIOPSIES
- 342 COMPARISON OF THE INCIDENCE OF SECONDARY CANCERS AFTER IMRT, BRACHYTHERAPY AND SURGERY FOR THE TREATMENT OF PROSTATE CANCER